Skip to main content
VTRS logo
VTRS
(NASDAQ)
Viatris Inc.
$17.28-- (--)
Loading... - Market loading

Viatris (VTRS) Stock Price & Financial Analysis

Viatris Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.76 - $17.28
52-Week High$17.68
52-Week Low$8.63
Open$16.88
Volume7.89M
Average Volume (3M)9.84M
Market Cap20.31B
Shares Outstanding1.18B
Price to Sales (P/S)1.39
Price to Book (P/B)1.39
EV/EBITDA12.81
Revenue (TTM)14.56B
Net Income (TTM)-296.50M
Free Cash Flow (TTM)1.72B
EPS (TTM)$-0.25
Profit Margin-2.04%
Operating Margin0.51%
Return on Equity (ROE)-2.02%
Debt to Equity0.98
50-Day MA$16.38
200-Day MA$13.72
52-Week Change84.42%
Annual Dividend$0.48
Dividend Yield2.78%
Last Dividend Ex-DateMay 22, 2026

Frequently Asked Questions About Viatris

What is the current stock price for VTRS?

As of the latest trading session, VTRS stock trades at $17.28. The 52-week range is $8.63–$17.68, with a day range of $16.75–$17.28.

What is the P/E ratio for VTRS?

The P/E ratio (Price-to-Earnings) for VTRS is shown in the Key Statistics section. This valuation metric helps compare Viatris Inc. to industry peers.

Does VTRS pay dividends?

Yes, Viatris pays a 2.78% annual dividend yield ($0.48 per share). The last ex-dividend date was 2026-05-22.

What do analysts recommend for VTRS?

Based on 7 analysts, the consensus for VTRS is Buy.

What is the market cap of VTRS?

Viatris's market capitalization is $20.31B, classifying it as a large-cap company. Viatris operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.